Marico
- Market Cap
- ₹1,19,227 Cr
- P/E
- 59.05
Key Fundamentals
LargecapConsumer GoodsFMCGPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 47.00%
- Debt to Equity
- 0.26
- EPS (TTM)
- ₹15.53
- Book Value
- ₹36.42
- Market Cap
- ₹1,19,227 Cr
- P/E (TTM)
- 59.05
- P/B
- 25.18
- ROE
- 42.90%
- Dividend Yield
- 0.44%
- EBITDA
- ₹2,532 Cr
- 52W High
- ₹925.00
- 52W Low
- ₹707.25
- Day Range
- ₹911.60 – ₹924.30
- Volume
- 15,56,130
Peer Comparison
Fast Moving Consumer Goods › Agricultural Food & other Products › Edible Oil
| 917.00 | 59.05 | 1,19,227 | 25.18 | 0.44% | 42.90% | 47.00% | 14,692 | 2,078 | |
| 404.20 | 23.46 | 43,981 | 3.27 | 0.20% | 16.00% | 12.10% | 44,299 | 1,874 | |
| 171.98 | 19.41 | 22,352 | 2.05 | 0.59% | 10.70% | 18.30% | 82,318 | 1,152 | |
| 213.45 | 13.54 | 6,299 | 3.71 | 0.00% | 30.00% | 36.70% | 25,277 | 466 | |
| 1,007.05 | 10.11 | 2,818 | 1.24 | 0.00% | 10.80% | 12.30% | 2,384 | 280 | |
| 724.60 | 108.15 | 1,603 | 12.24 | 0.14% | 33.70% | 19.80% | 597 | 15 | |
| 217.66 | 15.52 | 544 | 1.35 | 0.00% | 8.86% | 13.60% | 1,892 | 35 | |
| Median 7 companies | 404.20 | 19.41 | 6,299 | 3.27 | 0.14% | 16.00% | 18.30% | 14,692 | 466 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 78
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 26
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 70
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 88
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 77
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 52
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company has a good return on equity (ROE) track record: 3 Years ROE 41.0%
- Company has been maintaining a healthy dividend payout of 65.1%
Weaknesses
2- Stock is trading at 25.2 times its book value
- The company has delivered a poor sales growth of 11.1% over past five years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 2 | 3 | 14 |
| Oscillators | Bullish | 2 | 3 | 4 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Bullish
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 66.91
- Neutral
- MACD (12,26,9)
- 30.61
- Bullish
- SMA (50)
- 825.52
- Bullish
- SMA (200)
- 812.24
- Bullish
As of
Analyst Rating
34 of 38 analysts rate Buy, 4 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +8.51% |
|---|---|
| 5Y | +11.08% |
| 3Y | +11.71% |
| 1Y | +25.67% |
| TTM | +20.48% |
Net profit
| 10Y | +9.63% |
|---|---|
| 5Y | +8.62% |
| 3Y | +11.10% |
| 1Y | +9.35% |
| TTM | +22.52% |
Operating cash flow
| 10Y | +9.80% |
|---|---|
| 5Y | +0.76% |
| 3Y | +13.67% |
| 1Y | +52.90% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −0.37 pp |
|---|---|
| 5Y | −2.64 pp |
| 3Y | −1.44 pp |
| 1Y | −2.65 pp |
| TTM | −0.11 pp |
Revenue by year
| Mar 2017 | ₹5,918 Cr |
|---|---|
| Mar 2018 | ₹6,322 Cr |
| Mar 2019 | ₹7,334 Cr |
| Mar 2020 | ₹7,315 Cr |
| Mar 2021 | ₹8,048 Cr |
| Mar 2022 | ₹9,512 Cr |
| Mar 2023 | ₹9,764 Cr |
| Mar 2024 | ₹9,653 Cr |
| Mar 2025 | ₹10,831 Cr |
| Mar 2026 | ₹13,611 Cr |
Net profit by year
| Mar 2017 | ₹811 Cr |
|---|---|
| Mar 2018 | ₹827 Cr |
| Mar 2019 | ₹1,131 Cr |
| Mar 2020 | ₹1,043 Cr |
| Mar 2021 | ₹1,199 Cr |
| Mar 2022 | ₹1,255 Cr |
| Mar 2023 | ₹1,322 Cr |
| Mar 2024 | ₹1,502 Cr |
| Mar 2025 | ₹1,658 Cr |
| Mar 2026 | ₹1,813 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
As of 2026-11-17, Marico Ltd trades at ₹924 with a market cap of ₹1,20,137 crore, commanding a TTM P/E of 59.5x and a P/B of 25.37x. The company delivers a consistently high return on equity — 43% last year and a 3-year average of 41% — while maintaining a near debt-free balance sheet at a debt-to-equity ratio of 0.12. Revenue growth has accelerated to 20% on a TTM basis, though longer-term 5-year sales CAGR stands at 11%.
- Exceptional return on equity with last year's ROE at 43% and a 10-year average of 38%, indicating highly efficient capital allocation over long periods
- Near debt-free balance sheet with a debt-to-equity ratio of just 0.12, providing significant financial flexibility and resilience during downturns
- TTM revenue growth has accelerated sharply to 20%, a notable step-up from the 5-year compounded sales growth of 11%
- TTM profit growth of 21% outpaces the 10-year compounded profit growth of 10%, suggesting improving profitability and operating leverage
- Healthy dividend payout ratio of 65.1% signals management confidence in cash flow sustainability and a shareholder-friendly capital return policy
- Stock has delivered a 1-year return of 22% and a 3-year CAGR of 20%, reflecting strong recent price momentum
- ROCE of 39% complements the high ROE, confirming the business generates robust returns on total capital employed, not just equity
- The stock is trading at ₹924, within ₹1 of its 52-week high of ₹925, indicating sustained investor confidence and demand at current levels
- Price-to-book ratio of 25.37x means investors are paying a very steep premium over the company's book value of assets
- Five-year compounded sales growth of 11% is modest for a stock commanding such a premium valuation, raising questions about sustainable top-line expansion
- Dividend yield of just 0.44% offers minimal income return, meaning investor returns are almost entirely dependent on capital appreciation
- Ten-year compounded profit growth of 10% and sales growth of 9% suggest the long-run earnings trajectory is single-digit to low-double-digit, which the current P/E of 59.5x may not adequately reflect
- Five-year stock CAGR of 11% lags the more recent 3-year CAGR of 20%, indicating that a significant portion of returns are concentrated in the recent rally rather than being evenly distributed
- The gap between 5-year compounded profit growth of 9% and TTM profit growth of 21% raises the question of whether the current acceleration is cyclical rather than structural
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Marico delivered a standout Q2 FY27 with 31% PAT growth, record Parachute volumes, and a 45% surge in its foods portfolio, prompting an upgrade in full-year EBITDA guidance to mid-20s growth. The company is actively investing in market share (A&P up 44% YoY) and expanding via acquisitions in wellness and international digital channels. Key risks center on copra price normalization threatening the current margin tailwind, renewed input cost pressures from geopolitical tensions, and a deliberate near-term volume sacrifice in Saffola oils. The trend is firmly positive for now, but sustainability hinges on whether the aggressive brand investments translate into durable share gains when the commodity cycle turns.
- Input cost pressure flagged Nov 02
MD Saugata Gupta flagged renewed input cost pressures from geopolitical tensions in West Asia and weather-related concerns, with consumer inflation rising led by food, edible oil, and fuel.
- Copra reversal risk to margins Nov 02
Current 600 bps gross margin expansion was driven by copra prices sitting ~35% below peak. A normalization in copra prices would pressure the 18.2% EBITDA margin, especially with A&P running at an elevated 11.6% of revenue.
- Saffola oils volume decline Nov 02
Marico is deliberately sacrificing volumes at the low-margin end of Saffola edible oils, resulting in a high-single-digit volume decline in Q2 even as revenue grew 6% via premiumization.
- Q2 PAT surges 31% YoY Nov 02
Consolidated net profit jumped 31% YoY to ₹550 crore in Q2 FY27, the highest PAT growth in 51 quarters. EBITDA rose 27% to ₹709 crore with margin expanding 200 bps to 18.2%.
- Parachute volume best in 22 quarters Nov 02
Parachute Rigids posted 13% volume growth, its strongest in 22 quarters, gaining 570+ bps in market share to reach a record 60% volume share in coconut oil.
- Foods portfolio crosses ₹1,500 cr ARR Nov 02
The foods portfolio grew 45% YoY and crossed ₹1,500 crore annualized run rate, with profitability now ~5x FY26 levels and a target of 10x by FY30.
- Director spouse trading penalty Nov 20
Marico levied a ₹3 lakh penalty on Independent Director Bhaskar Bhat after his spouse inadvertently purchased 200 shares worth ₹1.79 lakh during a prohibited trading period on November 8, 2026.
- Rohit Jawa appointed as director Nov 02
Former HUL CEO Rohit Jawa was appointed as Additional Independent Director for a five-year term starting January 1, 2027, subject to shareholder approval.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,476 | 2,422 | 2,278 | 2,643 | 2,664 | 2,794 | 2,730 | 3,221 | 3,450 | 3,537 | 3,301 | 3,957 | 3,897 |
| Expenses | 1,979 | 1,909 | 1,836 | 2,017 | 2,142 | 2,261 | 2,272 | 2,566 | 2,890 | 2,945 | 2,780 | 3,138 | 3,188 |
| Operating Profit | 497 | 513 | 442 | 626 | 522 | 533 | 458 | 655 | 560 | 592 | 521 | 819 | 709 |
| OPM % | 20% | 21% | 19% | 24% | 20% | 19% | 17% | 20% | 16% | 17% | 16% | 21% | 18% |
| Other Income | 38 | 43 | 15 | 37 | 82 | 42 | 47 | 56 | 49 | 39 | 60 | 48 | 53 |
| Interest | 20 | 19 | 17 | 17 | 11 | 13 | 12 | 10 | 12 | 14 | 17 | 21 | 24 |
| Depreciation | 39 | 42 | 41 | 41 | 41 | 44 | 52 | 45 | 47 | 50 | 60 | 56 | 64 |
| PBT | 476 | 495 | 399 | 605 | 552 | 518 | 441 | 656 | 550 | 567 | 504 | 790 | 674 |
| Tax % | 24% | 22% | 20% | 22% | 22% | 22% | 22% | 22% | 21% | 19% | 19% | 17% | 17% |
| Net Profit | 360 | 386 | 320 | 474 | 433 | 406 | 345 | 513 | 432 | 460 | 408 | 652 | 558 |
| EPS (₹) | 2.73 | 2.96 | 2.46 | 3.58 | 3.27 | 3.08 | 2.65 | 3.89 | 3.24 | 3.44 | 3.01 | 4.85 | 4.23 |
| YoY Sales growth | −1 | −2 | 2 | 7 | 8 | 15 | 20 | 22 | 30 | 27 | 21 | 23 | 13 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,733 | 6,017 | 5,918 | 6,322 | 7,334 | 7,315 | 8,048 | 9,512 | 9,764 | 9,653 | 10,831 | 13,611 | 14,692 |
| Expenses | 4,863 | 4,966 | 4,759 | 5,185 | 6,009 | 5,846 | 6,459 | 7,831 | 7,954 | 7,627 | 8,692 | 11,283 | 12,051 |
| Operating Profit | 870 | 1,051 | 1,159 | 1,137 | 1,325 | 1,469 | 1,589 | 1,681 | 1,810 | 2,026 | 2,139 | 2,328 | 2,641 |
| OPM % | 15% | 17% | 20% | 18% | 18% | 20% | 20% | 18% | 19% | 21% | 20% | 17% | 18% |
| Other Income | 59 | 93 | 96 | 85 | 103 | 124 | 94 | 98 | 144 | 142 | 208 | 204 | 200 |
| Interest | 23 | 21 | 17 | 16 | 40 | 50 | 34 | 39 | 56 | 73 | 53 | 53 | 76 |
| Depreciation | 84 | 95 | 90 | 89 | 131 | 140 | 139 | 139 | 155 | 158 | 178 | 202 | 230 |
| Exceptional Items | — | — | — | — | — | −29 | 13 | — | — | — | — | — | — |
| PBT | 822 | 1,029 | 1,149 | 1,117 | 1,257 | 1,374 | 1,525 | 1,601 | 1,743 | 1,937 | 2,116 | 2,277 | 2,535 |
| Tax % | 29% | 30% | 29% | 26% | 10% | 24% | 21% | 22% | 24% | 22% | 22% | 20% | — |
| Net Profit | 585 | 723 | 811 | 827 | 1,135 | 1,043 | 1,199 | 1,255 | 1,322 | 1,502 | 1,658 | 1,813 | 2,078 |
| EPS (₹) | 4.45 | 5.51 | 6.19 | 6.31 | 8.63 | 7.91 | 9.08 | 9.48 | 10.07 | 11.44 | 12.57 | 13.57 | 15.53 |
| Div. Payout % | 28% | 77% | 57% | 67% | 55% | 85% | 83% | 97% | 45% | 83% | 83% | 30% | — |
| Sales growth | 22 | 5 | −2 | 7 | 16 | 0 | 10 | 18 | 3 | −1 | 12 | 26 | 20 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 64 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 130 | 130 |
| Reserves | 1,760 | 1,888 | 2,197 | 2,414 | 2,846 | 2,894 | 3,111 | 3,219 | 3,670 | 3,703 | 3,846 | 4,080 | 4,605 |
| Borrowings | 428 | 331 | 239 | 312 | 352 | 338 | 511 | 479 | 608 | 528 | 554 | 557 | 1,238 |
| Other Liabilities | 873 | 1,010 | 1,059 | 1,217 | 1,569 | 1,603 | 1,675 | 1,850 | 2,393 | 2,993 | 3,746 | 5,183 | 6,405 |
| Total Liabilities | 3,125 | 3,358 | 3,623 | 4,072 | 4,896 | 4,964 | 5,426 | 5,677 | 6,800 | 7,353 | 8,275 | 9,950 | 12,378 |
| Fixed Assets | 1,076 | 1,050 | 1,085 | 1,110 | 1,300 | 1,396 | 1,612 | 1,760 | 2,246 | 2,724 | 2,758 | 3,633 | 3,960 |
| CWIP | 3 | 37 | 11 | 27 | 45 | 58 | 24 | 39 | 67 | 44 | 40 | 85 | 144 |
| Investments | 284 | 544 | 608 | 543 | 450 | 733 | 854 | 828 | 1,096 | 602 | 1,590 | 2,083 | 2,634 |
| Other Assets | 1,763 | 1,727 | 1,919 | 2,392 | 3,101 | 2,777 | 2,936 | 3,050 | 3,391 | 3,983 | 3,887 | 4,149 | 5,640 |
| Total Assets | 3,125 | 3,358 | 3,623 | 4,072 | 4,896 | 4,964 | 5,426 | 5,677 | 6,800 | 7,353 | 8,275 | 9,950 | 12,378 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 665 | 818 | 649 | 516 | 1,062 | 1,214 | 2,007 | 1,016 | 1,419 | 1,387 | 1,363 | 2,084 |
| Investing | −186 | −203 | −125 | 59 | −367 | −22 | −933 | 441 | −928 | 176 | −621 | −722 |
| Financing | −625 | −601 | −574 | −567 | −698 | −1,147 | −1,058 | −1,290 | −560 | −1,542 | −649 | −1,279 |
| Net Cash Flow | −147 | 14 | −51 | 8 | −3 | 45 | 16 | 167 | −69 | 21 | 93 | 83 |
| Free Cash Flow | 607 | 731 | 567 | 388 | 919 | 1,034 | 1,870 | 884 | 1,237 | 1,234 | 1,241 | 1,772 |
| CFO/EBITDA | 101 | 101 | 82 | 71 | 104 | 102 | 144 | 81 | 99 | 87 | 86 | 114 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 15 | 15 | 20 | 26 | 27 | 18 | 25 | 38 | 40 | 43 | 35 |
| Inventory Days | 139 | 110 | 193 | 190 | 147 | 157 | 108 | 106 | 94 | 116 | 93 | 85 |
| Days Payable | 79 | 80 | 107 | 103 | 98 | 108 | 109 | 101 | 112 | 137 | 103 | 108 |
| Cash Conversion Cycle | 71 | 46 | 101 | 106 | 74 | 76 | 17 | 30 | 20 | 19 | 33 | 12 |
| Working Capital Days | 18 | 0 | 23 | 37 | 27 | 24 | −11 | 5 | 2 | 14 | 16 | −18 |
| ROCE % | 38% | 44% | 45% | 42% | 42% | 43% | 43% | 43% | 42% | 43% | 45% | 47% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Marico insights
64 extracted metrics across FY07–FY27.
Documents
- Q2 FY27 concall · Nov 2026Transcript PPT Recording
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT
- Concall · Feb 2026Transcript PPT
- Q3 FY26 concall · Jan 2026Transcript PPT Recording
- 2 Sep 2026
- 7 Jul 2025
- 25 Apr 2024
- 31 Mar 2023
- 12 Jan 2022
- 20 Nov 2026
- General announcements 13 Nov 2026
Frequently Asked Questions about Marico
What does Marico Ltd do?
Where is Marico Ltd (MARICO) listed?
Which sector does Marico Ltd belong to?
What is the market capitalisation of Marico Ltd?
What is the PE ratio of Marico Ltd?
What is the 52-week high and low of Marico Ltd?
Does Marico Ltd pay dividends?
What is the Return on Equity (ROE) of Marico Ltd?
Company Information
Marico Limited is one of India's leading consumer goods companies, operating across beauty, personal care, wellness and foods in India and select international markets. Portfolio includes Parachute, Saffola, Hair & Care, Nihar, Livon, Set Wet, Beardo, Just Herbs, True Elements, Plix, Cosmix and 4700BC; products reach 1 out of 3 Indians.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/MARICO.md for Marico Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.